Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
NCT04346992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2022-09-08
Summary
Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease
Conditions
- Keratoconus in Thyroid Gland Dysfunction
Interventions
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-12
- Primary Completion
- 2022-03-15
- Completion
- 2022-03-15
Countries
- Egypt
Study Locations
More Related Trials
-
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
NCT06590220 ·Status: RECRUITING
-
Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
NCT07059507 ·Status: RECRUITING
-
Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy
NCT03178253 ·Status: UNKNOWN
-
The Relation Between Thyroid , Parathyroid Hormones and eGFR in CKD Patients in Assiut
NCT05243979 ·Status: UNKNOWN
-
To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism
NCT06204393 ·Status: RECRUITING
-
Natural History of Thyroid Function Disorders
NCT00001159 ·Status: RECRUITING
-
Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
NCT01182584 ·Status: UNKNOWN
-
Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
NCT06179368 ·Status: RECRUITING
-
Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
NCT02339142 ·Status: UNKNOWN ·Phase: PHASE4
-
Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease
NCT05643365 ·Status: RECRUITING
-
Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
NCT03066076 ·Status: UNKNOWN ·Phase: PHASE3
-
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
NCT01204359 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
NCT06275373 ·Status: RECRUITING
-
A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease
NCT07265258 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Impact of Hypothyroidism on Tear Production and Dry Eye Symptoms: Implications for Optometric Care
NCT06913465 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Thyroid Dysfunction in Patients Undergoing Haemodialysis at Sohag University Hospital
NCT07022236 ·Status: RECRUITING
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
Heart Rate Monitoring by Wearable Devices in Graves' Disease
NCT04333342 ·Status: UNKNOWN ·Phase: NA
-
Association of TTGA (Tissue Transglutaminase Antibody) and Histopathologic Findings in Thyroidectomy Patients
NCT04974255 ·Status: UNKNOWN ·Phase: NA
-
Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease
NCT02376088 ·Status: COMPLETED
-
Relationship Between Thyroid Dysfunction and Diabetes
NCT07099937 ·Status: NOT_YET_RECRUITING
-
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
NCT01801033 ·Status: WITHDRAWN
-
Association Between Thyroid Dysfunction and Intensive Care Unit Acquired Weaknesss
NCT04313101 ·Status: UNKNOWN
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
NCT07152340 ·Status: RECRUITING ·Phase: PHASE4